These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22169080)

  • 1. Covariate adjustment increased power in randomized controlled trials: an example in traumatic brain injury.
    Turner EL; Perel P; Clayton T; Edwards P; Hernández AV; Roberts I; Shakur H; Steyerberg EW;
    J Clin Epidemiol; 2012 May; 65(5):474-81. PubMed ID: 22169080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?
    Roozenbeek B; Maas AI; Lingsma HF; Butcher I; Lu J; Marmarou A; McHugh GS; Weir J; Murray GD; Steyerberg EW;
    Crit Care Med; 2009 Oct; 37(10):2683-90. PubMed ID: 19885979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted Unfavorable Neurologic Outcome Is Overestimated by the Marshall Computed Tomography Score, Corticosteroid Randomization After Significant Head Injury (CRASH), and International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Models in Patients with Severe Traumatic Brain Injury Managed with Early Decompressive Craniectomy.
    Charry JD; Tejada JH; Pinzon MA; Tejada WA; Ochoa JD; Falla M; Tovar JH; Cuellar-Bahamón AM; Solano JP
    World Neurosurg; 2017 May; 101():554-558. PubMed ID: 28223249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a prognostic score for early mortality in severe head injury cases.
    Gómez PA; de-la-Cruz J; Lora D; Jiménez-Roldán L; Rodríguez-Boto G; Sarabia R; Sahuquillo J; Lastra R; Morera J; Lazo E; Dominguez J; Ibañez J; Brell M; de-la-Lama A; Lobato RD; Lagares A
    J Neurosurg; 2014 Dec; 121(6):1314-22. PubMed ID: 25237737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustment for strong predictors of outcome in traumatic brain injury trials: 25% reduction in sample size requirements in the IMPACT study.
    Hernández AV; Steyerberg EW; Butcher I; Mushkudiani N; Taylor GS; Murray GD; Marmarou A; Choi SC; Lu J; Habbema JD; Maas AI
    J Neurotrauma; 2006 Sep; 23(9):1295-303. PubMed ID: 16958582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting in-hospital mortality after traumatic brain injury: External validation of CRASH-basic and IMPACT-core in the national trauma data bank.
    Camarano JG; Ratliff HT; Korst GS; Hrushka JM; Jupiter DC
    Injury; 2021 Feb; 52(2):147-153. PubMed ID: 33070947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between-centre differences and treatment effects in randomized controlled trials: a case study in traumatic brain injury.
    Lingsma HF; Roozenbeek B; Perel P; Roberts I; Maas AI; Steyerberg EW
    Trials; 2011 Aug; 12():201. PubMed ID: 21867540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
    Brennan PM; Murray GD; Teasdale GM
    J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation and Recalibration of Risk Prediction Models for Acute Traumatic Brain Injury among Critically Ill Adult Patients in the United Kingdom.
    Harrison DA; Griggs KA; Prabhu G; Gomes M; Lecky FE; Hutchinson PJ; Menon DK; Rowan KM;
    J Neurotrauma; 2015 Oct; 32(19):1522-37. PubMed ID: 25898072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
    Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
    Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of progesterone for severe traumatic brain injury.
    Skolnick BE; Maas AI; Narayan RK; van der Hoop RG; MacAllister T; Ward JD; Nelson NR; Stocchetti N;
    N Engl J Med; 2014 Dec; 371(26):2467-76. PubMed ID: 25493978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients.
    van Leeuwen N; Lingsma HF; Perel P; Lecky F; Roozenbeek B; Lu J; Shakur H; Weir J; Steyerberg EW; Maas AI; ; ;
    Neurosurgery; 2012 Apr; 70(4):811-8; discussion 818. PubMed ID: 21904253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: a systematic review.
    Hernández AV; Steyerberg EW; Taylor GS; Marmarou A; Habbema JD; Maas AI
    Neurosurgery; 2005 Dec; 57(6):1244-53; discussion 1244-53. PubMed ID: 16331173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.
    Kahan BC; Jairath V; Doré CJ; Morris TP
    Trials; 2014 Apr; 15():139. PubMed ID: 24755011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression discontinuity was a valid design for dichotomous outcomes in three randomized trials.
    van Leeuwen N; Lingsma HF; Mooijaart SP; Nieboer D; Trompet S; Steyerberg EW
    J Clin Epidemiol; 2018 Jun; 98():70-79. PubMed ID: 29486280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome Prediction of TBI: Are There Parameters That Affect the IMPACT and CRASH Models?
    Bilgi K; Gopalakrishna KN; Chakrabarti D; Rao GSU
    World Neurosurg; 2021 Feb; 146():e590-e596. PubMed ID: 33130284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic models.
    Roozenbeek B; Lingsma HF; Lecky FE; Lu J; Weir J; Butcher I; McHugh GS; Murray GD; Perel P; Maas AI; Steyerberg EW; ; ;
    Crit Care Med; 2012 May; 40(5):1609-17. PubMed ID: 22511138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
    Xiao G; Wei J; Yan W; Wang W; Lu Z
    Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.